A Study on the Dynamic Capabilities of Firms and Competitive Advantages-Based on the Adjusting Pharmaceutical Price for Transnational Pharmaceutical Companies
碩士 === 國立東華大學 === 管理學院高階經營管理碩士在職專班 === 101 === Taiwan NHI had announced seventh NHI drug price adjustment on December2011. Cut the expenditures on drugs about 15 billion Taiwan dollars.Drug industry and hospital system triggered a rebound. Some foreign pharmaceutical companies consider to withdraw t...
Main Authors: | Sheng-Syong Cao, 曹勝雄 |
---|---|
Other Authors: | Sheng-Syong Tsao |
Format: | Others |
Published: |
2013
|
Online Access: | http://ndltd.ncl.edu.tw/handle/73uasz |
Similar Items
-
COMPETITION AMONG TRANSNATIONAL COMPANIES IN THE PHARMACEUTICAL INDUSTRY
by: Alina Voiculet
Published: (2014-11-01) -
Organizational Capability and Competitive Advantage in Pharmaceutical Product Development
by: Kenichi KUWASHIMA
Published: (2003-04-01) -
The strategy of pharmaceutical companies under the NHI drug price adjustment case study of an original pharmaceutical company
by: Wen-tai Lin, et al.
Published: (2009) -
Process Capability and Price Evaluation Chart For A Pharmaceutical Company
by: Sündüz Dağ, et al.
Published: (2015-06-01) -
Price regulation, competitions and pharmaceutical prices
by: Ya-Wen Lee, et al.
Published: (2018)